- Report
- January 2026
- 326 Pages
Global
From €4084EUR$4,500USD£3,488GBP
- Report
- September 2025
- 100 Pages
Global
From €4447EUR$4,900USD£3,798GBP
- Report
- April 2026
- 146 Pages
Global
From €2722EUR$2,999USD£2,325GBP
€3630EUR$3,999USD£3,100GBP
- Report
- April 2026
- 137 Pages
Global
From €2722EUR$2,999USD£2,325GBP
€3630EUR$3,999USD£3,100GBP
- Report
- April 2026
- 141 Pages
Global
From €2722EUR$2,999USD£2,325GBP
€3630EUR$3,999USD£3,100GBP
- Report
- October 2025
- 150 Pages
Global
From €5400EUR$5,950USD£4,612GBP
- Report
- May 2026
- 150 Pages
Global
From €5400EUR$5,950USD£4,612GBP
- Report
- May 2026
- 150 Pages
Global
From €5400EUR$5,950USD£4,612GBP
- Report
- October 2025
- 150 Pages
Global
From €5400EUR$5,950USD£4,612GBP
- Report
- July 2026
- 278 Pages
Global
From €5310EUR$5,850USD£4,535GBP
- Report
- June 2026
- 195 Pages
Global
From €3217EUR$3,545USD£2,748GBP
€3575EUR$3,939USD£3,054GBP
- Report
- June 2026
- 194 Pages
Global
From €3217EUR$3,545USD£2,748GBP
€3575EUR$3,939USD£3,054GBP
- Report
- June 2026
- 183 Pages
Global
From €3217EUR$3,545USD£2,748GBP
€3575EUR$3,939USD£3,054GBP
- Report
- June 2026
- 192 Pages
Global
From €3217EUR$3,545USD£2,748GBP
€3575EUR$3,939USD£3,054GBP
- Report
- June 2026
- 190 Pages
Global
From €3217EUR$3,545USD£2,748GBP
€3575EUR$3,939USD£3,054GBP
- Report
- June 2026
- 181 Pages
Global
From €3217EUR$3,545USD£2,748GBP
€3575EUR$3,939USD£3,054GBP
- Report
- June 2026
- 196 Pages
Global
From €3217EUR$3,545USD£2,748GBP
€3575EUR$3,939USD£3,054GBP
- Report
- June 2026
- 182 Pages
Global
From €3217EUR$3,545USD£2,748GBP
€3575EUR$3,939USD£3,054GBP
- Report
- January 2026
- 186 Pages
Global
From €3218EUR$3,545USD£2,748GBP
€3575EUR$3,939USD£3,054GBP
- Report
- June 2026
- 184 Pages
Global
From €3217EUR$3,545USD£2,748GBP
€3575EUR$3,939USD£3,054GBP

A diagnostic biomarker is a biological molecule or gene that is used to identify a particular disease or condition. It is used to diagnose, monitor, and predict the progression of a disease or condition. Diagnostic biomarkers are used to detect the presence of a disease or condition, to determine the severity of the disease or condition, and to monitor the effectiveness of treatments. Diagnostic biomarkers are used in a variety of medical fields, including oncology, neurology, cardiology, and infectious diseases.
Diagnostic biomarkers are typically identified through a variety of methods, including genetic sequencing, proteomics, and metabolomics. These methods allow for the identification of biomarkers that are specific to a particular disease or condition.
The diagnostic biomarker market is a rapidly growing field, with many companies developing and marketing diagnostic biomarkers. Companies in this market include Illumina, Thermo Fisher Scientific, Qiagen, Roche, and Agilent Technologies. Show Less Read more